UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 42

Sortiert nach

Myelopreservation with the CDK4/6 inhibitor trilaciclib in patients with small-cell lung cancer receiving first-line chemotherapy: a phase Ib/randomized phase II trial

Annals of oncology, 2019-10, Vol.30 (10), p.1613-1621

2019

Volltextzugriff (PDF)

Replacement of bortezomib with carfilzomib for multiple myeloma patients progressing from bortezomib combination therapy

Leukemia, 2014-07, Vol.28 (7), p.1529-1536

2014

Volltextzugriff (PDF)

Effects of enobosarm on muscle wasting and physical function in patients with cancer: a double-blind, randomised controlled phase 2 trial

The lancet oncology, 2013-04, Vol.14 (4), p.335-345

2013

Volltextzugriff (PDF)

ZIO-101 (S-dimethylarsino-glutathione): Phase I/II trials in advanced/progressive multiple myeloma

Journal of clinical oncology, 2007-06, Vol.25 (18_suppl), p.8109-8109

2007

Volltextzugriff (PDF)

A phase II, multicenter, open-label randomized study of motesanib or bevacizumab in combination with paclitaxel and carboplatin for advanced nonsquamous non-small-cell lung cancer

Annals of oncology, 2011-09, Vol.22 (9), p.2057-2067

2011

Volltextzugriff (PDF)

Can biosimilars help achieve the goals of US health care reform?

Cancer management and research, 2017-01, Vol.9, p.197-205

2017

Volltextzugriff (PDF)

In response to Dr. Hicsonmez et al

International journal of radiation oncology, biology, physics, 2005-03, Vol.61 (4), p.1279-1279

Boccia, Ralph

2005

Volltextzugriff (PDF)

Improved tolerability of amifostine with rapid infusion and optimal patient preparation

Seminars in oncology, 2002-12, Vol.29 (6 Suppl 19), p.9-13, Article asonc02906t0009

Boccia, Ralph

2002

Volltextzugriff (PDF)

Pharmacokinetics, safety, and efficacy of APF530 (extended-release granisetron) in patients receiving moderately or highly emetogenic chemotherapy: results of two Phase II trials

Cancer management and research, 2015-01, Vol.7 (default), p.83-92

2015

Volltextzugriff (PDF)

Assessment and management of cutaneous reactions with amifostine administration: Findings of the ethyol (amifostine) cutaneous treatment advisory panel (ECTAP)

International journal of radiation oncology, biology, physics, 2004-09, Vol.60 (1), p.302-309

2004

Volltextzugriff (PDF)

A multicenter randomized clinical trial evaluating interleukin-2 activated hematopoietic stem cell transplantation and post-transplant IL-2 for high risk breast cancer patients

Breast cancer research and treatment, 2005-09, Vol.93 (2), p.125-134

2005

Volltextzugriff (PDF)

Multiple recurrences of acute tumor lysis syndrome in an indolent non‐hodgkin's lymphoma

Cancer, 1985-11, Vol.56 (9), p.2295-2297

1985

Volltextzugriff (PDF)

A dose-finding and safety study of novel erythropoiesis stimulating protein (NESP) for the treatment of anaemia in patients receiving multicycle chemotherapy

British journal of cancer, 2001-04, Vol.84 (S1), p.17-23

2001

Volltextzugriff (PDF)

Molecular Gene Expression Profiling to Predict the Tissue of Origin and Direct Site-Specific Therapy in Patients With Carcinoma of Unknown Primary Site: A Prospective Trial of the Sarah Cannon Research Institute

Journal of clinical oncology, 2013-01, Vol.31 (2), p.217-223

2013

Volltextzugriff (PDF)

Alcohol and cigarette consumption predict mortality in patients with head and neck cancer: a pooled analysis within the International Head and Neck Cancer Epidemiology (INHANCE) Consortium

Annals of oncology, 2017-11, Vol.28 (11), p.2843-2851

2017

Volltextzugriff (PDF)

Patient-Reported Outcomes Data From REVEAL at the Time of Enrollment (Baseline): A Prospective Observational Study of Patients With Polycythemia Vera in the United States

Clinical lymphoma, myeloma and leukemia, 2018-09, Vol.18 (9), p.590-596

2018

Volltextzugriff (PDF)

Prevalence and risk factors of extrapancreatic malignancies in a large cohort of patients with intraductal papillary mucinous neoplasm (IPMN) of the pancreas

Annals of oncology, 2013-07, Vol.24 (7), p.1907-1911

2013

Volltextzugriff (PDF)

Osimertinib in Untreated EGFR-Mutated Advanced Non–Small-Cell Lung Cancer

The New England journal of medicine, 2018-01, Vol.378 (2), p.113-125

2018

Volltextzugriff (PDF)

Amsa: A phase II trial in resistant and recurrent acute myelogenous leukemia

Medical and pediatric oncology, 1984, Vol.12 (3), p.178-179

1984

Volltextzugriff (PDF)

Phase II trial of preoperative pemetrexed plus carboplatin in patients with stage IB-III nonsquamous non-small cell lung cancer (NSCLC)

Lung cancer (Amsterdam, Netherlands), 2018-04, Vol.118, p.6-12

2018

Volltextzugriff (PDF)

A Phase II Trial of Panobinostat, a Histone Deacetylase Inhibitor, in the Treatment of Patients with Refractory Metastatic Renal Cell Carcinoma

Cancer investigation, 2011-08, Vol.29 (7), p.451-455

2011

Volltextzugriff (PDF)

Prognostic factors and outcomes in Italian patients undergoing curative gastric cancer surgery

European journal of surgical oncology, 2014-03, Vol.40 (3), p.345-351

2014

Volltextzugriff (PDF)

Efficacy and tolerability of transdermal granisetron for the control of chemotherapy-induced nausea and vomiting associated with moderately and highly emetogenic multi-day chemotherapy: a randomized, double-blind, phase III study

Supportive care in cancer, 2011-10, Vol.19 (10), p.1609-1617

2011

Volltextzugriff (PDF)

1 – 25 von 42

Suche als RSS-Feed

Aktive Filter

ThemaOncology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(41)
Mit Volltextzugriff
(39)

Publikationsform

Artikel
(42)

Sprache

Englisch
(42)
Japanisch
(4)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(41)
Science & Technology
(41)
Humans
(35)
Female
(30)
Middle Aged
(28)
Male
(26)
Aged
(25)
Adult
(18)
Aged, 80 And Over
(14)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(13)
Biological And Medical Sciences
(12)
Medical Sciences
(12)
Treatment Outcome
(9)
Prognosis
(7)
Survival Rate
(7)
Antineoplastic Agents
(6)
Chemotherapy
(6)
Disease-Free Survival
(6)
Hematology
(6)

14 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Myelopreservation with the CDK4/6 inhibitor trilaciclib in patients with small-cell lung cancer receiving first-line chemotherapy: a phase Ib/randomized phase II trial

Replacement of bortezomib with carfilzomib for multiple myeloma patients progressing from bortezomib combination therapy

Effects of enobosarm on muscle wasting and physical function in patients with cancer: a double-blind, randomised controlled phase 2 trial

ZIO-101 (S-dimethylarsino-glutathione): Phase I/II trials in advanced/progressive multiple myeloma

A phase II, multicenter, open-label randomized study of motesanib or bevacizumab in combination with paclitaxel and carboplatin for advanced nonsquamous non-small-cell lung cancer

Can biosimilars help achieve the goals of US health care reform?

In response to Dr. Hicsonmez et al

Improved tolerability of amifostine with rapid infusion and optimal patient preparation

Pharmacokinetics, safety, and efficacy of APF530 (extended-release granisetron) in patients receiving moderately or highly emetogenic chemotherapy: results of two Phase II trials

Assessment and management of cutaneous reactions with amifostine administration: Findings of the ethyol (amifostine) cutaneous treatment advisory panel (ECTAP)

A multicenter randomized clinical trial evaluating interleukin-2 activated hematopoietic stem cell transplantation and post-transplant IL-2 for high risk breast cancer patients

Multiple recurrences of acute tumor lysis syndrome in an indolent non‐hodgkin's lymphoma

A dose-finding and safety study of novel erythropoiesis stimulating protein (NESP) for the treatment of anaemia in patients receiving multicycle chemotherapy

Molecular Gene Expression Profiling to Predict the Tissue of Origin and Direct Site-Specific Therapy in Patients With Carcinoma of Unknown Primary Site: A Prospective Trial of the Sarah Cannon Research Institute

Alcohol and cigarette consumption predict mortality in patients with head and neck cancer: a pooled analysis within the International Head and Neck Cancer Epidemiology (INHANCE) Consortium

Patient-Reported Outcomes Data From REVEAL at the Time of Enrollment (Baseline): A Prospective Observational Study of Patients With Polycythemia Vera in the United States

Prevalence and risk factors of extrapancreatic malignancies in a large cohort of patients with intraductal papillary mucinous neoplasm (IPMN) of the pancreas

Osimertinib in Untreated EGFR-Mutated Advanced Non–Small-Cell Lung Cancer

Amsa: A phase II trial in resistant and recurrent acute myelogenous leukemia

Phase II trial of preoperative pemetrexed plus carboplatin in patients with stage IB-III nonsquamous non-small cell lung cancer (NSCLC)

A Phase II Trial of Panobinostat, a Histone Deacetylase Inhibitor, in the Treatment of Patients with Refractory Metastatic Renal Cell Carcinoma

Prognostic factors and outcomes in Italian patients undergoing curative gastric cancer surgery

Lung cancer multi-omics digital human avatars for integrating precision medicine into clinical practice: the LANTERN study

Overexpression of Both CXC Chemokine Receptor 4 and Vascular Endothelial Growth Factor Proteins Predicts Early Distant Relapse in Stage II-III Colorectal Cancer Patients

Efficacy and tolerability of transdermal granisetron for the control of chemotherapy-induced nausea and vomiting associated with moderately and highly emetogenic multi-day chemotherapy: a randomized, double-blind, phase III study

Aktive Filter

Suchergebnisse filtern